Your trusted source for investing success

Tag: pfizer

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Beleave Announces Significant Appointments to its Board of Directors

Beleave Announces Significant Appointments to its Board of Directors

Beleave Inc. (“Beleave” or the “Company”) (CSE:BE; OTCQX:BLEVF) is pleased to announce the appointment of Mark Heselton and Mark Miles to the Company’s Board of Directors.

“We see these additions as transformational and on behalf of the entire Company we would like to welcome Mark and Mark to the team.” Commented Beleave CEO Andrew Wnek, “Their

5 Alzheimer’s Disease Treatment Stocks

5 Alzheimer’s Disease Treatment Stocks

Alzheimer’s and other forms of dementia cost the US health care system over $259 billion in 2017, and may increase to over $1.1 trillion by 2050. Here’s a look at five Alzheimer disease treatment stocks for investor consideration.

What Is In-Licensing?

What Is In-Licensing?

Licensing deals might be pharma’s preferred mode of business development these days—perhaps even more so than outright acquisitions.

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top Weekly NASDAQ Biotech Stocks: Novelion on Top

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/5-top-weekly-nasdaq-biotech-stocks/